PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,061,068 | -24.8% | 34,585 | -1.7% | 0.10% | -20.6% |
| Q2 2023 | $1,410,103 | +0.4% | 35,191 | +2.3% | 0.13% | -7.4% |
| Q1 2023 | $1,404,272 | +7.1% | 34,410 | +1.3% | 0.14% | +3.8% |
| Q4 2022 | $1,311,196 | -25.3% | 33,960 | +2.9% | 0.13% | -33.8% |
| Q3 2022 | $1,755,000 | -6.5% | 33,002 | +2.5% | 0.20% | -0.5% |
| Q2 2022 | $1,878,000 | -20.1% | 32,210 | +4.6% | 0.20% | -11.9% |
| Q1 2022 | $2,350,000 | +29.8% | 30,791 | +2.3% | 0.23% | +40.4% |
| Q4 2021 | $1,811,000 | +105.1% | 30,102 | +90.9% | 0.16% | +78.9% |
| Q3 2021 | $883,000 | -3.0% | 15,769 | +5.2% | 0.09% | +1.1% |
| Q2 2021 | $910,000 | -8.3% | 14,992 | +5.9% | 0.09% | -14.4% |
| Q1 2021 | $992,000 | – | 14,160 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |